STAT3 and osteosarcoma: Furthermore, our clinical samples showed increased expression of p-STAT3, MRP and MDR-1 in chemoresistant tumors, suggesting that the STAT3-associated genes may be relevant to poor outcomes of osteosarcoma chemotherapy.